This Up-and-Coming Healthcare Stock Could Skyrocket

With its novel Tumor Treating Fields therapy that uses electrical pulses to treat cancer, Novocure (NASDAQ: NVCR) could offer new hope to patients and physicians. In this Motley Fool Live segment from The Pharma & Biotech Show, recorded on March 23, Fool.com contributors Taylor Carmichael and Keith Speights consider whether Novocure has the potential to emerge beyond a niche treatment option. 

Continue reading

Source Fool.com